baber/WOPTO huggingface dataset:
Patent DE-69033103-D1 (DE)
Inventor: VAN GORCOM ROBERT FRANCISCUS M
IPC: A23K1/165
Filed: 1990-09-27
Granted: 1999-06-17
Abstract: A nucleotide sequence encoding phytase has been isolated and cloned. The coding sequence has been inserted into an expression construct which in turn has been inserted into a vector capable of transforming a microbial expression host. The transformed microbial hosts may be used to economically produce phytase on an industrial scale. The compositions comprising phytase produced via the present invention may be used in a variety of processes requiring the conversion of phytate to inositol and inorganic phosphate.
Patent DE-69033556-D1 (DE)
Inventor: COTTONE ANDREW JOHN
IPC: F28F19/06
Filed: 1990-07-25
Granted: 2000-07-06
Abstract: Potential difficulties with corrosion resistance in air cooled condensers utilizing aluminum fins are avoided by using fin and tube constructions made by a method which includes the steps of providing a flattened tube (50) of ferrous material (80) and having an exterior coating (82) predominantly of aluminum; providing at least one serpentine fin (56) of aluminum (86) and clad with a predominantly aluminum braze cladding (88); assembling (102) the fin (56) to the flattened tube (50); applying (94), (100), (104), a brazing flux to at least one of the fin (56) and the tube (50); raising (106) the temperature of the assembly to a level sufficient to at least partially melt the braze cladding (88); and maintaining the temperature for a sufficient Period of time to achieve a brazed joint (60) between the fin (56) and the tube (50) but a time insufficient to convert the coating (82) and the cladding (88) to ferrous-aluminum intermetallic compound or intermediate phase.
Patent DE-69034209-D1 (DE)
Inventor: MONTGOMERY A
IPC: A61K31/708
Filed: 1990-09-14
Granted: 2006-01-05
Abstract: 2'-Deoxy-4'-thio-ribonucleosides, intermediates in their production, and their use as antiviral and anticancer agents are disclosed.
Patent DE-69101293-D1 (DE)
Inventor: ROSSE MEINRAD
IPC: B65D81/20
Filed: 1991-08-27
Granted: 1994-04-07
Abstract: The invention relates to a rigid residual-vacuum container with a metal closure cap (5) with a deformable central part, comprising a tamper-indicating means including a ring (2) integral with the said closure cap and a central patch (3) in a single portion connected to the said ring via at least 2 fastening lugs (4), the said patch being separated from the ring on opening of the closure cap. <IMAGE>
Patent DE-69101790-D1 (DE)
Inventor: TOSHIKI MORI
IPC: C07C403/14
Filed: 1991-01-02
Granted: 1994-06-01
Abstract: The invention provide a process for producing vitamin A aldehyde in high yield by oxidizing vitamin A with a aldehyde of the general formula (1) <CHEM> wherein R1, R5 and R3 are the same or different and respectively represents a lower alkyl group or a lower alkenyl group in the presence of an aluminum alkoxide or aluminum phenoxide in a catalytic amount.
Patent DE-69108785-D1 (DE)
Inventor: CHANTRY WILLIAM AMDOR
IPC: D01F6/62
Filed: 1991-06-13
Granted: 1995-05-18
Abstract: Polyester of high intrinsic viscosity is spun, steam-heated, drawn and wound up in a multi-stage continuous process to provide an improved monofilament that is particularly suited for reinforcing rubber, e.g. in tires, after suitable dip-coating, stretching and setting. <IMAGE>
Patent DE-69111726-D1 (DE)
Inventor: HO SA VAN
IPC: C07K14/655
Filed: 1991-09-09
Granted: 1995-09-07
Abstract: A method for the solubilization and naturation of somatotropin from refractile bodies produced by r-DNA technology wherein the refractile bodies are dissolved in an aqueous solution comprising a chaotropic agent such as urea or guanidine hydrochloride and a soluble surfactant such as sodium dodecylsulfate. The solubilized protein is exposed to mild oxidation for a time sufficient to allow the protein to form disulfide bonds and refold to its native conformation. The presence of the surfactant suppresses the formation of somatotropin dimers and aggregates and results in higher yields of the desirable monomeric form of the protein.
Patent DE-69113385-D1 (DE)
Inventor: STEF FRANCINE
IPC: A61B19/00
Filed: 1991-10-09
Granted: 1995-11-02
Abstract: Orthopaedic equipment   The brace is characterised by the fact that:   the telescopic components (7, 8), are made of an X-ray transparent material and form two transverse plates (9 and 10) at their opposite ends; the locking device (11) is composed of a slide (12) working in conjunction with two chucks (13 and 14) fitted to the periphery of the plates; the position-adjusting devices, for each flange, are made up of three threaded rods (40), angularly equidistant, individually adjustable as to length and mounted in the corresponding plate by means of three ball and socket joints.     Application to the reduction of long-bone fractures.   <IMAGE>   <IMAGE>
Patent DE-69129956-D1 (DE)
Inventor: NORRIS DAVID
IPC: G11C7/00
Filed: 1991-02-12
Granted: 1998-09-17
Abstract: An information storage apparatus for first-in-first-out storage and output of information comprising a plurality of storage cells, an input circuit for sequentially delivering information to the storage cells, and a control circuit for controlling the operation of the apparatus in response to at least one clocked signal. The storage cells are arranged to effect serial progression of information therethrough in a predetermined sequence to an output, all in response to the control circuit. The control circuit directs the information to the empty of the plurality of storage cells which is most proximate to the output of the apparatus by the input circuit which provides parallel inverse representations of the information to the storage cells.
Patent DE-69130482-D1 (DE)
Inventor: WOOD KEITH
IPC: C12Q1/66
Filed: 1991-09-09
Granted: 1998-12-17
Abstract: Methods and compositions are provided for improved kinetics of light production from luciferase activity in beetle luciferase-luciferin reactions. Thus, the invention provides methods, compositions and test kits for assaying samples for the presence of a beetle luciferase or, using a beetle luciferase-luciferin reaction, the presence of ATP. The invention also provides the complex of the coenzyme, Coenzyme A, a beetle luciferase and oxyluciferin in its exited state in the luciferase-luciferin reaction and luciferyl-CoA, the thioester of Coenzyme A and luciferin (D-(-)-2-(6'-hydroxy-2'-benzothiazolyl)- DELTA 2-thiazoline-4-carboxylic acid).
Patent DE-69133060-D1 (DE)
Inventor: YOUNG PATRICK
IPC: H04N5/775
Filed: 1991-09-10
Granted: 2002-08-08
Abstract: Screen (10) for a user interface of a television schedule system and process consists of an array (24) of irregular cells (26), which vary in length, corresponding to different program lengths of one half to one-and-one half hours or more. Because of the widely varying length of the cells (26), if a conventional cursor used to select a cell location were to simply step from one cell to another, the result would be abrupt changed in the screen (10). By restricting cursor movements to the regular cells, abrupt screen changes will be avoided. A conventional offset shadow (34) which is a black bar underlines the entire cell and wraps around the right edge of the cell. To tag the underlying position which defines where the cursor (32) is and thus, where it will move next portions (36) of the black bar outside the current underlying position are segmented, while the current position is painted solid.
Patent DE-69232134-D1 (DE)
Inventor: SOLANKI KISHOR KHANDUBHAI
IPC: C07D471/04
Filed: 1992-08-21
Granted: 2001-11-22
Abstract: PCT No. PCT/GB92/01548 Sec. 371 Date May 12, 1993 Sec. 102(e) Date May 12, 1993 PCT Filed Aug. 21, 1992 PCT Pub. No. WO93/03772 PCT Pub. Date Mar. 4, 1993.A 4-quinolone antibiotic compound is used in gamma ray scintigraphy diagnostic imaging of a patient with a metallic radionuclide so as to locate focal infection.
Patent DE-69313462-D1 (DE)
Inventor: REYNOLDS ANDREW JOHN
IPC: B65D79/00
Filed: 1993-12-23
Granted: 1997-10-02
Abstract: PCT No. PCT/GB93/02639 Sec. 371 Date Jun. 20, 1995 Sec. 102(e) Date Jun. 20, 1995 PCT Filed Dec. 23, 1993 PCT Pub. No. WO94/14678 PCT Pub. Date Jul. 7, 1994Devices are described for fitting into pressurized individually packaged beverages (typically canned beers, ales and stouts), by which gas at high pressure is stored within the package for jetting into the beverage as the package is opened to atmosphere. One embodiment comprises a length of tube (10) having a gas jetting orifice (14) which in use is submerged below the beverage in a pressurized can having a gaseous headspace, which can be used to charge the tube with gas during the passage of the filled can (16) along a conventional canning line, on which the can is inverted after filling which brings the orifice into the gaseous headspace. A more preferred design of device comprises a molded plastics capsule (34; 50;78) secured near the bottom of a can (20, 88) with an internal, preferably central, pipe (56; 62; 80) to provide a liquid seal to prevent loss of gas when the can is inverted from the upright position, and an airlock when the can is upright, to prevent beverage which has entered the capsule from leaving it when the can is opened to atmosphere. A further design of capsule (96) having a central internal pipe (98) and adapted to be pressurized solely by the ingress of beverage, which is fitted midway down the can (94) but which still only jets gas on opening, is also described.
Patent DE-69316660-D1 (DE)
Inventor: YOUNG JAMES
IPC: A61K31/445
Filed: 1993-08-03
Granted: 1998-02-26
Abstract: Use of a composition comprising a compound of formula I:   
or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in providing symptomatic relief from dermal irritation, wherein the induction of cardiac arrhythmia is avoided, said treatment comprising administering a therapeutically effective amount of a compound of formula I to a human patient whose hepatic function is not impaired.
Patent DE-69328900-D1 (DE)
Inventor: KOENIG AXEL
IPC: C11D3/00
Filed: 1993-08-03
Granted: 2000-07-27
Abstract: The present invention relates to the use of stable aqueous compositions for the cleaning of carpets which comprise a source of active oxygen. Said composition has a pH of from 1 to 6.
Patent DE-69329064-D1 (DE)
Inventor: HAKANSSON OLOF
IPC: F01L13/06
Filed: 1993-05-27
Granted: 2000-08-24
Abstract: PCT No. PCT/SE93/00467 Sec. 371 Date Dec. 16, 1994 Sec. 102(e) Date Dec. 16, 1994 PCT Filed May 27, 1993 PCT Pub. No. WO93/25803 PCT Pub. Date Dec. 23, 1993Methods and apparatus for engine retardation in multi-cylinder combustion engines are disclosed including a hydraulic clearance regulator for regulating the clearance in a valve controller in response to a hydraulic fluid pressure below a predetermined maximum value in which the angular position of the crankshaft of the engine at which the exhaust valve in one of the engine cylinders is operated by an extra ridge on the camshaft is determined by the clearance in the valve controller. A pressure relief valve maintains the hydraulic fluid pressure below the predetermined maximum value, and a controller gradually reduces the clearance towards zero while the hydraulic fluid pressure in the valve controller is maintained below the predetermined maximum value so that the risk of operating the exhaust valve during a cylinder pressure greater than a predetermined elevated cylinder pressure is substantially reduced.
Patent DE-69331695-D1 (DE)
Inventor: WHISSON MAXWELL EDMUND
IPC: A61M5/34
Filed: 1993-04-21
Granted: 2002-04-18
Abstract: PCT No. PCT/AU93/00175 Sec. 371 Date Jan. 18, 1995 Sec. 102(e) Date Jan. 18, 1995 PCT Filed Apr. 21, 1993 PCT Pub. No. WO93/20872 PCT Pub. Date Oct. 28, 1993A parenteral device (10) comprising a body (12) having a forward end (26) and a rearward end (34). The forward end (26) is capable of receiving a hollow retractable needle (20) therein so as to project therefrom. The retractable needle (20) is slidable relative to the body (12) and the body (12) also includes a chamber (14) capable of receiving parenteral fluid and capable of being reduced in volume to expel fluid contained therein. The needle (20) is capable of being manually retracted within the body (12) such that the chamber (14) reduces in volume to expel fluid contained therein and such that the needle (20) is retracted to be wholly contained within the body (12).
Patent DE-69332240-D1 (DE)
Inventor: SAKON KIYOYUKI
IPC: A61K9/72
Filed: 1993-06-11
Granted: 2002-10-02
Abstract: An ultrafine powder for inhalation to be transferred mainly to the lower airway, which comprises a drug and hydroxypropylcellulose and/or hydroxypropylmethylcellulose and wherein the particles having diameters in the range of 0.5-10  mu m account for 80 wt.% or above.
Patent DE-69334070-D1 (DE)
Inventor: GOODWIN RAYMOND G
IPC: C07K14/705
Filed: 1993-05-25
Granted: 2006-11-16
Abstract: There is disclosed a polypeptide (CD30-L) and DNA sequences, vectors and transformed host cells useful in providing CD30-L polypeptides. The CD30-L polypeptide binds to the receptor known as CD30, which is expressed on a number of cell types, among which are Hodgkin's Disease tumor cells, large cell anaplastic lymphoma cells, adult T-cell leukemia (T-ALL) cells, and a number of other malignant cell types. CD30-L polypeptides find use as carriers for delivering diagnostic and cytotoxic agents to cells expressing the CD30 receptor.
Patent DE-69401591-D1 (DE)
Inventor: EUDIER JEAN-YVES
IPC: B66C13/06
Filed: 1994-08-12
Granted: 1997-03-06
Abstract: PCT No. PCT/FR94/01005 Sec. 371 Date Feb. 13, 1996 Sec. 102(e) Date Feb. 13, 1996 PCT Filed Aug. 12, 1994 PCT Pub. No. WO95/05336 PCT Pub. Date Feb. 23, 1995Method and device for controlling the swinging motion of an oscillating load suspended from a movable support, wherein the movement of the support is controlled by a speed setpoint. The method includes a step (AS1) for automatically controlling the actual swaying value of the oscillating load by means of a zero swaying value and a step (37) for adjusting the speed setpoint (CV) of the support according to a correction value (E1) determined during the automatic swaying control step (AS1). The invention can be used, for example, for moving a load by means of a harbour crane.
Patent DE-69433690-D1 (DE)
Inventor: DUNN J
IPC: C07K14/20
Filed: 1994-10-27
Granted: 2004-05-13
Abstract: Novel chimeric nucleic acids, encoding chimeric Borrelia proteins consisting of at least two antigenic polypeptides from corresponding and/or non-corresponding proteins from the same and/or different species of Borrelia, are disclosed. Chimeric proteins encoded by the nucleic acid sequences are also disclosed. The chimeric proteins are useful as vaccine immunogens against Lyme borreliosis, as well as for immunodiagnostic reagents.
Patent DE-69502819-D1 (DE)
Inventor: BARBIC LENART
IPC: G01N33/42
Filed: 1995-03-20
Granted: 1998-07-09
Abstract: PCT No. PCT/SI95/00006 Sec. 371 Date Sep. 20, 1996 Sec. 102(e) Date Sep. 20, 1996 PCT Filed Mar. 20, 1995 PCT Pub. No. WO95/25964 PCT Pub. Date Sep. 28, 1995According to the method for controlling the grinding of mineral raw materials, at a predetermined value i* of the impregnation level to which the fines of the specimen are impregnated by the impregnating agent, the effective spin-lattice relaxation time of the impregnating agent protons is measured. Each time the parameters of the grinding process are set so that the approximation s'NMR for the specific surface area of the fines will attain a prescribed value soNMR. Each time the residue percentage of the fines retained on a sieve is determined and at the onset of an increase of the residue percentage the grinding is controlled so that a subsequent agglomeration of fines particles is suppressed. The fines are impregnated by a liquid impregnanting agent comprising hydrogen atoms. In the appliance of the invention the measuring and control unit comprises a measuring unit consisting of a measuring vessel and a digital automatic analytical balance, which are preferably situated in vacuum tank, and a nuclear magnetic resonance spectrometer with coherent pulses. According to the proposed method the grinding control is based on a detected agglomeration of fine particles of the fines.
Patent DE-69502838-D1 (DE)
Inventor: ZACHARIAS DONALD
IPC: B22D11/10
Filed: 1995-10-24
Granted: 1998-07-09
Abstract: A tundish impact pad (20) to reduce turbulence in the tundish comprises a body of refractory material capable of withstanding contact with molten steel in a tundish (10), the body comprising a base (22) having an impact surface (24), an outer sidewall (26, 40) extending upwardly from the impact surface (24), a top surface (32) connected to the sidewall (26, 40) and defining an opening (30) therein, in which the top surface (32) has an inner annular portion (42) substantially parallel to the impact surface (24), and the sidewall (26, 40) has an interior face (28) which is substantially perpendicular to the impact surface (24) and wherein a substantially right angle corner (28A) is provided between the sidewall (28) and the impact surface (24) and a substantially right angle corner is provided between the sidewall (28) and the top surface inner annular portion (42).
Patent DE-69504034-D1 (DE)
Inventor: DEKKER ODULFUS
IPC: B65B13/04
Filed: 1995-01-24
Granted: 1998-09-17
Abstract: PCT No. PCT/NL95/00035 Sec. 371 Date Oct. 29, 1996 Sec. 102(e) Date Oct. 29, 1996 PCT Filed Jan. 24, 1995 PCT Pub. No. WO95/19913 PCT Pub. Date Jul. 27, 1995A device for arranging a band of flexible material, in particular paper or plastic, round at least one product. The device includes a feed mechanism for feeding band material from a supply roll, an assembly for forming a loop in an end portion of the band material round a space for receiving the product, an assembly for severing that end portion and a welding assembly for closing the loop.\!
Patent DE-69504102-D1 (DE)
Inventor: HANNAGAN ANGUS
IPC: A61G7/057
Filed: 1995-12-20
Granted: 1998-09-17
Abstract: A chair, particularly a wheelchair (1), has a detachable active calf support (4), which has a plurality of inflatable cushion members (A, B, C, D) providing a calf support surface for a person in the chair. The cushion members are parallel transverse tubes forming an array extending away from the chair seat (3). The chair has a control for inflating and deflating the tubes in a predetermined sequence.
Patent DE-69511561-D1 (DE)
Inventor: BALSANO ANTONIO RENATO
IPC: A22C17/08
Filed: 1995-07-11
Granted: 1999-09-23
Abstract: Composition useful for decontaminating surfaces of food products of animal and vegetable origin, in particular for eliminating microbic loadings and unsanitary substances, without altering and making noxious the food texture; a method is moreover disclosed for using said composition, comprising the steps of subjecting the food product to a bath of an aqueous solution of the composition and subsequently rinsing by water in order to remove the polluting substances being present.
Patent DE-69521752-D1 (DE)
Inventor: YABUTA MASAYUKI
IPC: C12N1/21
Filed: 1995-09-06
Granted: 2001-08-23
Abstract: A process for the production of a desired polypeptide comprising the steps of: (1) transforming host cells with an expression vector comprising a gene coding for a fusion protein comprising a desired polypeptide and a protective polypeptide; (2) culturing the transformed host cells so as to express said gene to produce a fusion protein; and (3) excising the desired polypeptide from the fusion protein with a protease intrinsic to the host cells. A large amount of a desired polypeptide can be produced at a low cost. Especially according to the present invention, a large amount of S. aureus V8 protease can be efficiently produced at low cost using a safe host as E. coli according to gene recombination procedures.
Patent DE-69523189-D1 (DE)
Inventor: MELO MARIA L
IPC: G06F13/364
Filed: 1995-01-20
Granted: 2001-11-22
Abstract: An arbiter which allows retried requests to have high priority in subsequent arbitrations by not changing priority on a granted, but aborted, access to the bus and yet prevents the aborted requestor from thrashing the bus by masking its bus request signal until the data is available. Further, should an access to main memory be retried, all bus requests except the one from the memory system are masked to provide the memory system the highest effective priority to allow any flushing operations to occur. The masking of the various bus requests allows the arbiter to control access to a PCI standard bus without requiring that specific signals be added. The arbiter further includes modified priority LRU techniques and provides a locking requestor with an additional, highest priority position if retried. <IMAGE>
Patent DE-69524596-D1 (DE)
Inventor: TOWNSON JANE KAREN
IPC: A01N25/24
Filed: 1995-06-07
Granted: 2002-01-24
Abstract: An aqueous solution composition which is an aqueous herbicidal glyphosate concentrate comprises (i) N-phosphonomethylglycine or an agriculturally acceptable salt thereof, (ii) a alkylpolyglycoside surfactant and (iii) an ethoxylated alcohol wherein the ethoxylated alcohol is obtained by ethoxylation of a branched chain aliphatic mono alcohol or a mixture of linear and branched chain aliphatic mono alcohols having an average chain length of from 8 to 20 carbon atoms or of an aromatic alcohol and has a mean degree of ethoxylation of from 2 to 50 moles of ethylene oxide per mole of alcohol and wherein wherein the proportion of alkylpolyglycoside is from 1 part by weight of alkylpolyglycoside per 5 parts by weight of ethoxylated alcohol to 8 parts by weight of alkylpolyglycoside per 1 part by weight of ethoxylated alcohol, and optionally (iv) an additional surfactant and optionally (v) a humectant.
Patent DE-69531069-D1 (DE)
Inventor: ZUCCATO ALESSANDRO
IPC: A61K35/14
Filed: 1995-11-30
Granted: 2003-07-17
Abstract: An immunopheresis of immunoadsorption method for substracting, according to different cases, specifically selected pathogenic factors (i.e. HIV virus, and/or gp120 antigen, and/or gp120/antibodies anti-gp120 immunocomplexes, and/or TNF- alpha , and/or interleukins (IL1 beta , IL4, IL6, IL8, IL10), and/or soluble HLA molecules, and/or gp41 protein, and/or immunocomplexes formed by gp41 and human anti-gp41 antibodies) whose presence is increased during a HIV virus infection and which is directly correlated to a state of acquired immunodeficiency. According to a form of embodiment, a method is provided for the specific immunoadsorption of said pathogenic factors, which comprises drawing blood from a patient affected with a given pathology, adsorbing the pathogenic factors which are present in said blood by using specific ligands (i.e. monoclonal and/or polyclonal anti-gp120 antibodies, and/or anti-HLA antibodies, and/or anti-gp41 antibodies, and/or recombinant CD4 molecules, and/or anti-CD4 antibodies, and/or GNA (Galanthus Nivalis Agglutinin) lectin, and/or a peptide fragment of C1q protein and/or native or recombinant C1q protein, and/or modified or non-modified Staphylococcus aureus A protein, and/or Streptococcus G protein, and/or anti-TNF- alpha  antibodies, and/or anti-interleukins antibodies) in order to obtain blood featuring a low concentration of pathogenic factors.
Patent DE-69532914-D1 (DE)
Inventor: GALLOWAY JOHN ALLISON
IPC: A61K47/42
Filed: 1995-05-23
Granted: 2004-05-27
Abstract: The present invention provides novel complexes consisting of certain GLP-1 molecules associated with a divalent metal cation that is capable of co-precipitating with a GLP-1 molecule. Pharmaceutical compositions and methods of using such complexes for enhancing the expression of insulin in B-type islet cells is claimed, as is a method for treating maturity onset diabetes mellitus in mammals, particularly humans.